This study looked at the predictive effects of parenting processes and family functioning on depressive symptoms and suicidal ideation in a randomized controlled trial of integrated cognitive-behavioral therapy vs. treatment as usual for adolescents with comorbid SUDs and psychiatric disorders.
With COVID-19 having truly disastrous effects, the study authors sought to uncover the toll of substance abuse during the pandemic.
Researchers compared the rate at which patients diagnosed with both depression and a substance use disorder received acute and continuous pharmacotherapy and psychotherapy with the rate at which patients solely diagnosed with depression received the same treatments.
Adults with chronic back pain who had adverse allergic reactions to NSAIDs are at higher risk for developing an opioid use disorder.
There have been few studies that have examined the specificity of mood disorder subtypes among the children of parents with both major subtypes of mood disorders and controls based on prospective tracking across the transition from childhood to adulthood.
Substance use disorder is associated with a higher risk for COVID-19 than that seen in the general population, as well as worse outcomes.
Researchers used data from the National Health and Nutrition Examination Survey 2009-2018 to assess the impact of drug and alcohol use on cardiometabolic disease risk factors.
Behavioral management of chronic pain may improve addiction treatment outcomes.
The 10-item progress assessment tool represents a pragmatic approach to ongoing monitoring in substance use disorders.
Cannabidiol (CBD) may be a safe and effective treatment option for cannabis use disorder.
